LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Apellis Pharmaceuticals and Millions of Other Companies

Sign up for full access to Apellis Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Key Therapeutic Focus Apellis Pharmaceuticals is committed to developing transformative therapies for diseases by targeting the complement system, providing sales opportunities for niche market segments with unmet medical needs.

Strategic Restructuring Recent headcount reduction and operational restructuring in Europe suggest a focus on optimizing resources, signaling potential cost-efficient solutions for healthcare providers interested in Apellis' therapies.

Investment and Partnerships Significant investments from firms like Jacobs Levy Equity Management and Handelsinvest, along with strategic partnerships, indicate confidence in Apellis' growth potential, presenting partnership or investment opportunities for synergistic collaborations.

Leadership Addition Hiring Dr. Philip Ferrone as Chief Medical Retina Advisor enhances Apellis' expertise, showcasing a reinforcement of their medical team and potentially opening avenues for collaborations with experts in the field.

Financial Stability and Market Position With a revenue in the $100M - 1B range and substantial funding, Apellis Pharmaceuticals demonstrates financial strength and market positioning, offering stability and growth potential for potential investors or buyers looking to engage in the biotechnology sector.

Similar companies to Apellis Pharmaceuticals

✕

Access Insights for Apellis Pharmaceuticals and Millions of Other Companies

Sign up for full access to Apellis Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Apellis Pharmaceuticals Tech Stack

Apellis Pharmaceuticals uses 8 technology products and services including Anaplan, ADP Workforce Now, Veeva Systems, and more. Explore Apellis Pharmaceuticals's tech stack below.

  • Anaplan
    Corporate Performance Management
  • ADP Workforce Now
    Human Capital Management
  • Veeva Systems
    IT Infrastructure & Operations Management
  • jQuery
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • DocuSign
    Miscellaneous
  • Microsoft Teams
    Team Collaboration
  • Drupal Multisite
    Web Hosting

Media & News

Apellis Pharmaceuticals's Email Address Formats

Apellis Pharmaceuticals uses at least 1 format(s):
Apellis Pharmaceuticals Email FormatsExamplePercentage
First.Last@apellis.comJohn.Doe@apellis.com
92%
First@apellis.comJohn@apellis.com
6%
Last@apellis.comDoe@apellis.com
1%
Last_First@apellis.comDoe_John@apellis.com
1%

Frequently Asked Questions

Where is Apellis Pharmaceuticals's headquarters located?

Minus sign iconPlus sign iconApellis Pharmaceuticals's main headquarters is located at 100 Fifth Ave 3rd Floor Waltham, MA 02451 US. The company has employees across 5 continents, including North AmericaEuropeOceania.

What is Apellis Pharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact Apellis Pharmaceuticals's main corporate office by phone at
✕

Access Insights for Apellis Pharmaceuticals and Millions of Other Companies

Sign up for full access to Apellis Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-502-241-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Apellis Pharmaceuticals's stock symbol?

Minus sign iconPlus sign iconApellis Pharmaceuticals is a publicly traded company; the company's stock symbol is APLS.

What is Apellis Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconApellis Pharmaceuticals's official website is apellis.com and has social profiles on LinkedIn.

How much revenue does Apellis Pharmaceuticals generate?

Minus sign iconPlus sign icon As of September 2024, Apellis Pharmaceuticals's annual revenue reached $750M.

What is Apellis Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconApellis Pharmaceuticals's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Apellis Pharmaceuticals have currently?

Minus sign iconPlus sign iconAs of September 2024, Apellis Pharmaceuticals has approximately 770 employees across 5 continents, including North AmericaEuropeOceania. Key team members include Chief Research Officer (cro): L. S.Chief People Officer: K. L.Chief Technical Operations Officer: N. N.. Explore Apellis Pharmaceuticals's employee directory with LeadIQ.

What industry does Apellis Pharmaceuticals belong to?

Minus sign iconPlus sign iconApellis Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Apellis Pharmaceuticals use?

Minus sign iconPlus sign iconApellis Pharmaceuticals's tech stack includes AnaplanADP Workforce NowVeeva SystemsjQueryMicrosoftDocuSignMicrosoft TeamsDrupal Multisite.

What is Apellis Pharmaceuticals's email format?

Minus sign iconPlus sign iconApellis Pharmaceuticals's email format typically follows the pattern of . Find more Apellis Pharmaceuticals email formats with LeadIQ.

How much funding has Apellis Pharmaceuticals raised to date?

Minus sign iconPlus sign icon As of September 2024, Apellis Pharmaceuticals has raised $475M in funding. The last funding round occurred on May 14, 2024 for $475M.

When was Apellis Pharmaceuticals founded?

Minus sign iconPlus sign iconApellis Pharmaceuticals was founded in 2008.
Apellis Pharmaceuticals

Apellis Pharmaceuticals

Biotechnology ResearchMassachusetts, United States501-1000 Employees

At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. You can view our community guidelines here: Community guidelines: http://bit.ly/476Q8

✕

Access Insights for Apellis Pharmaceuticals and Millions of Other Companies

Sign up for full access to Apellis Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
100 Fifth Ave 3rd Floor Waltham, MA 02451 US
Phone number
✕

Access Insights for Apellis Pharmaceuticals and Millions of Other Companies

Sign up for full access to Apellis Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-502-241-****
Website
apellis.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
APLS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
501-1000

Section iconMedia & News

Section iconFunding & Financials

  • $475M

    Apellis Pharmaceuticals has raised a total of $475M of funding over 11 rounds. Their latest funding round was raised on May 14, 2024 in the amount of $475M.

  • $100M$1B

    Apellis Pharmaceuticals's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $475M

    Apellis Pharmaceuticals has raised a total of $475M of funding over 11 rounds. Their latest funding round was raised on May 14, 2024 in the amount of $475M.

  • $100M$1B

    Apellis Pharmaceuticals's revenue is in the range of $100M$1B

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Apellis Pharmaceuticals and Millions of Other Companies

Sign up for full access to Apellis Pharmaceuticals information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.